INA6 cell-derived human soluble IL-6 receptor was detected as a marker for MM tumor growth 4 weeks after the inoculation of INA6 cells in all the SCID-rab mice, which demonstrates that the rabbit bone microenvironment allows the growth of INA6 cells. This evidence concerns the gene AGFG1 and Miyoshi myopathy.